Document is current
Any future updates will be listed below
-
Authors
Harada, Hiroaki https://orcid.org/0000-0001-5566-9973
Shoda, Hirofumi https://orcid.org/0000-0002-1536-0303
Tsuchiya, Haruka https://orcid.org/0000-0002-2114-7656
Misaki, Makoto https://orcid.org/0000-0002-5385-657X
Sawada, Takayuki https://orcid.org/0009-0005-5920-183X
Fujio, Keishi https://orcid.org/0000-0001-7276-5254
- License Information
-
More Information
Article History
Received: 12 November 2023
Accepted: 27 January 2024
First Online: 8 March 2024
Declarations
:
: KF receives speaking fees and research support from Eli Lilly and Company; HT receives speaking fees from Eli Lilly and Company; and the other authors have no conflict of interest to declare.
: Written informed consent was obtained from the patients or their relatives for publication of this article. Our review processes were approved by the Research Ethics Committee of the University of Tokyo (approval number 2431, final version approved on 21 December 2022).
